Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis

BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with drug-eluting stents remains uncertain. We compared short-term (<6-month) DAPT followed by aspirin or P2Y12 inhibitor monotherapy; midterm (6-month) DAPT; 12-month DAPT; and extended-...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Safi U., Singh, Maninder, Valavoor, Shahul, Khan, Muhammad U., Lone, Ahmad N., Khan, Muhammad Zia, Khan, Muhammad Shahzeb, Mani, Preethi, Kapadia, Samir R., Michos, Erin D., Stone, Gregg W., Kalra, Ankur, Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547897/
https://www.ncbi.nlm.nih.gov/pubmed/32795096
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547897/
https://www.ncbi.nlm.nih.gov/pubmed/32795096
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046308

Ejemplares similares